Abstract Background Patients with lung cancer and interstitial disease treated radiotherapy are at risk of developing radiation pneumonitis. However, the association between abnormalities (ILAs) pneumonitis in patients limited-stage small-cell (LS-SCLC) remains unclear. Furthermore, prognosis is uncertain for SCLC ILAs chemoradiotherapy. We investigated impact on assessed LS-SCLC Methods retros...